Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Jul;52(7):481–489. doi: 10.1136/jcp.52.7.481

Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours.

J F Graadt van Roggen 1, J V Bovée 1, J Morreau 1, P C Hogendoorn 1
PMCID: PMC501486  PMID: 10605398

Abstract

Sarcomas account for approximately 1-2% of human malignant disease and are relatively uncommon. Histopathological study of these mesenchymal tumours at light microscopic and ultrastructural level may not always provide an unambiguous diagnosis. It has become apparent with the identification of increasing numbers of tumour specific genetic alterations that (cyto) genetic evaluation could become a very helpful adjunct to histopathological assessment in reaching a correct diagnosis. Thus, once the different tumour types can be accurately identified and classified, more meaningful clinical trials can be initiated to evaluate and select optimal methods of management. In addition, an increasing awareness and understanding of the molecular changes associated with, and the genetic variability in, the various tumour groups is beginning to provide important new information about clinical progression and prognosis.

Full text

PDF
481

Images in this article

482Image
on p.482
483Image
on p.483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe S., Imamura T., Park P., Nakano H., Okita H., Hata J., Tateishi A. Small round-cell type of malignant peripheral nerve sheath tumor. Mod Pathol. 1998 Aug;11(8):747–753. [PubMed] [Google Scholar]
  2. Angervall L., Enzinger F. M. Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer. 1975 Jul;36(1):240–251. doi: 10.1002/1097-0142(197507)36:1<240::aid-cncr2820360127>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  3. Argani P., Zakowski M. F., Klimstra D. S., Rosai J., Ladanyi M. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol. 1998 Jan;11(1):65–71. [PubMed] [Google Scholar]
  4. Ashar H. R., Fejzo M. S., Tkachenko A., Zhou X., Fletcher J. A., Weremowicz S., Morton C. C., Chada K. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell. 1995 Jul 14;82(1):57–65. doi: 10.1016/0092-8674(95)90052-7. [DOI] [PubMed] [Google Scholar]
  5. Askin F. B., Rosai J., Sibley R. K., Dehner L. P., McAlister W. H. Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer. 1979 Jun;43(6):2438–2451. doi: 10.1002/1097-0142(197906)43:6<2438::aid-cncr2820430640>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  6. Barr F. G., Biegel J. A., Sellinger B., Womer R. B., Emanuel B. S. Molecular and cytogenetic analysis of chromosomal arms 2q and 13q in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 1991 Mar;3(2):153–161. doi: 10.1002/gcc.2870030212. [DOI] [PubMed] [Google Scholar]
  7. Barr F. G., Galili N., Holick J., Biegel J. A., Rovera G., Emanuel B. S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993 Feb;3(2):113–117. doi: 10.1038/ng0293-113. [DOI] [PubMed] [Google Scholar]
  8. Bridge J. A., Bhatia P. S., Anderson J. R., Neff J. R. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 1993 Sep;69(2):79–90. doi: 10.1016/0165-4608(93)90080-6. [DOI] [PubMed] [Google Scholar]
  9. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. E., Bishop J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984 Jun 8;224(4653):1121–1124. doi: 10.1126/science.6719137. [DOI] [PubMed] [Google Scholar]
  10. Brody R. I., Ueda T., Hamelin A., Jhanwar S. C., Bridge J. A., Healey J. H., Huvos A. G., Gerald W. L., Ladanyi M. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol. 1997 Mar;150(3):1049–1058. [PMC free article] [PubMed] [Google Scholar]
  11. Caron H., van Sluis P., de Kraker J., Bökkerink J., Egeler M., Laureys G., Slater R., Westerveld A., Voûte P. A., Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med. 1996 Jan 25;334(4):225–230. doi: 10.1056/NEJM199601253340404. [DOI] [PubMed] [Google Scholar]
  12. Clark J., Rocques P. J., Crew A. J., Gill S., Shipley J., Chan A. M., Gusterson B. A., Cooper C. S. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994 Aug;7(4):502–508. doi: 10.1038/ng0894-502. [DOI] [PubMed] [Google Scholar]
  13. Davis R. J., D'Cruz C. M., Lovell M. A., Biegel J. A., Barr F. G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 1994 Jun 1;54(11):2869–2872. [PubMed] [Google Scholar]
  14. DeLorimier A. A., Bragg K. U., Linden G. Neuroblastoma in childhood. Am J Dis Child. 1969 Sep;118(3):441–450. doi: 10.1001/archpedi.1969.02100040443005. [DOI] [PubMed] [Google Scholar]
  15. Delattre O., Zucman J., Melot T., Garau X. S., Zucker J. M., Lenoir G. M., Ambros P. F., Sheer D., Turc-Carel C., Triche T. J. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994 Aug 4;331(5):294–299. doi: 10.1056/NEJM199408043310503. [DOI] [PubMed] [Google Scholar]
  16. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., de Jong P., Rouleau G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992 Sep 10;359(6391):162–165. doi: 10.1038/359162a0. [DOI] [PubMed] [Google Scholar]
  17. Dias P., Kumar P., Marsden H. B., Gattamaneni H. R., Heighway J., Kumar S. N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int J Cancer. 1990 Apr 15;45(4):593–596. doi: 10.1002/ijc.2910450403. [DOI] [PubMed] [Google Scholar]
  18. Dias P., Parham D. M., Shapiro D. N., Webber B. L., Houghton P. J. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol. 1990 Dec;137(6):1283–1291. [PMC free article] [PubMed] [Google Scholar]
  19. Downing J. R., Head D. R., Parham D. M., Douglass E. C., Hulshof M. G., Link M. P., Motroni T. A., Grier H. E., Curcio-Brint A. M., Shapiro D. N. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol. 1993 Nov;143(5):1294–1300. [PMC free article] [PubMed] [Google Scholar]
  20. ENZINGER F. M. CLEAR-CELL SARCOMA OF TENDONS AND APONEUROSES. AN ANALYSIS OF 21 CASES. Cancer. 1965 Sep;18:1163–1174. doi: 10.1002/1097-0142(196509)18:9<1163::aid-cncr2820180916>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  21. Fellinger E. J., Garin-Chesa P., Triche T. J., Huvos A. G., Rettig W. J. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol. 1991 Aug;139(2):317–325. [PMC free article] [PubMed] [Google Scholar]
  22. Fletcher C. D. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992 Mar;16(3):213–228. [PubMed] [Google Scholar]
  23. Fletcher J. A., Kozakewich H. P., Hoffer F. A., Lage J. M., Weidner N., Tepper R., Pinkus G. S., Morton C. C., Corson J. M. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med. 1991 Feb 14;324(7):436–442. doi: 10.1056/NEJM199102143240702. [DOI] [PubMed] [Google Scholar]
  24. Gerald W. L., Miller H. K., Battifora H., Miettinen M., Silva E. G., Rosai J. Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol. 1991 Jun;15(6):499–513. [PubMed] [Google Scholar]
  25. Gerald W. L., Rosai J., Ladanyi M. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1028–1032. doi: 10.1073/pnas.92.4.1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Giovannini M., Biegel J. A., Serra M., Wang J. Y., Wei Y. H., Nycum L., Emanuel B. S., Evans G. A. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest. 1994 Aug;94(2):489–496. doi: 10.1172/JCI117360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Graadt van Roggen J. F., Mooi W. J., Hogendoorn P. C. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol. 1998 Sep;186(1):3–7. doi: 10.1002/(SICI)1096-9896(199809)186:1<3::AID-PATH153>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  28. Hecht J. T., Hogue D., Strong L. C., Hansen M. F., Blanton S. H., Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. 1995 May;56(5):1125–1131. [PMC free article] [PubMed] [Google Scholar]
  29. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998 Jan 23;279(5350):577–580. doi: 10.1126/science.279.5350.577. [DOI] [PubMed] [Google Scholar]
  30. Jeon I. S., Davis J. N., Braun B. S., Sublett J. E., Roussel M. F., Denny C. T., Shapiro D. N. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995 Mar 16;10(6):1229–1234. [PubMed] [Google Scholar]
  31. Jhanwar S. C., Chen Q., Li F. P., Brennan M. F., Woodruff J. M. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet. 1994 Dec;78(2):138–144. doi: 10.1016/0165-4608(94)90081-7. [DOI] [PubMed] [Google Scholar]
  32. Kawai A., Woodruff J., Healey J. H., Brennan M. F., Antonescu C. R., Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998 Jan 15;338(3):153–160. doi: 10.1056/NEJM199801153380303. [DOI] [PubMed] [Google Scholar]
  33. Kelly K. M., Womer R. B., Sorensen P. H., Xiong Q. B., Barr F. G. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol. 1997 May;15(5):1831–1836. doi: 10.1200/JCO.1997.15.5.1831. [DOI] [PubMed] [Google Scholar]
  34. Knezevich S. R., McFadden D. E., Tao W., Lim J. F., Sorensen P. H. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998 Feb;18(2):184–187. doi: 10.1038/ng0298-184. [DOI] [PubMed] [Google Scholar]
  35. Komuro H., Hayashi Y., Kawamura M., Hayashi K., Kaneko Y., Kamoshita S., Hanada R., Yamamoto K., Hongo T., Yamada M. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res. 1993 Nov 1;53(21):5284–5288. [PubMed] [Google Scholar]
  36. Labelle Y., Zucman J., Stenman G., Kindblom L. G., Knight J., Turc-Carel C., Dockhorn-Dworniczak B., Mandahl N., Desmaze C., Peter M. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet. 1995 Dec;4(12):2219–2226. doi: 10.1093/hmg/4.12.2219. [DOI] [PubMed] [Google Scholar]
  37. Ladanyi M. The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol. 1995 Sep;4(3):162–173. doi: 10.1097/00019606-199509000-00003. [DOI] [PubMed] [Google Scholar]
  38. Legius E., Dierick H., Wu R., Hall B. K., Marynen P., Cassiman J. J., Glover T. W. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer. 1994 Aug;10(4):250–255. doi: 10.1002/gcc.2870100405. [DOI] [PubMed] [Google Scholar]
  39. Mandahl N., Heim S., Arheden K., Rydholm A., Willén H., Mitelman F. Multiple karyotypic rearrangements, including t(X;18)(p11;q11), in a fibrosarcoma. Cancer Genet Cytogenet. 1988 Feb;30(2):323–327. doi: 10.1016/0165-4608(88)90202-6. [DOI] [PubMed] [Google Scholar]
  40. Meier V. S., Kühne T., Jundt G., Gudat F. Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations. Diagn Mol Pathol. 1998 Feb;7(1):29–35. doi: 10.1097/00019606-199802000-00006. [DOI] [PubMed] [Google Scholar]
  41. Melo J. V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996 Oct 1;88(7):2375–2384. [PubMed] [Google Scholar]
  42. Mertens F., Rydholm A., Bauer H. F., Limon J., Nedoszytko B., Szadowska A., Willén H., Heim S., Mitelman F., Mandahl N. Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer. 1995 Jun 9;61(6):793–798. doi: 10.1002/ijc.2910610609. [DOI] [PubMed] [Google Scholar]
  43. Nawa G., Ueda T., Mori S., Yoshikawa H., Fukuda H., Ishiguro S., Funai H., Uchida A. Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas. Int J Cancer. 1996 Apr 22;69(2):86–91. doi: 10.1002/(SICI)1097-0215(19960422)69:2<86::AID-IJC3>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  44. Noguera R., Navarro S., Triche T. J. Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet. 1990 Mar;45(1):121–124. doi: 10.1016/0165-4608(90)90074-k. [DOI] [PubMed] [Google Scholar]
  45. Pagani A., Fischer-Colbrie R., Eder U., Pellin A., Llombart-Bosch A., Bussolati G. Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int J Cancer. 1995 Nov 27;63(5):738–743. doi: 10.1002/ijc.2910630522. [DOI] [PubMed] [Google Scholar]
  46. Panagopoulos I., Mandahl N., Ron D., Höglund M., Nilbert M., Mertens F., Mitelman F., Aman P. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res. 1994 Dec 15;54(24):6500–6503. [PubMed] [Google Scholar]
  47. Pedeutour F., Simon M. P., Minoletti F., Barcelo G., Terrier-Lacombe M. J., Combemale P., Sozzi G., Ayraud N., Turc-Carel C. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996;72(2-3):171–174. doi: 10.1159/000134178. [DOI] [PubMed] [Google Scholar]
  48. Presant C. A., Russell W. O., Alexander R. W., Fu Y. S. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol. 1986 Nov;4(11):1658–1661. doi: 10.1200/JCO.1986.4.11.1658. [DOI] [PubMed] [Google Scholar]
  49. Pritchard D. J., Dahlin D. C., Dauphine R. T., Taylor W. F., Beabout J. W. Ewing's sarcoma. A clinicopathological and statistical analysis of patients surviving five years or longer. J Bone Joint Surg Am. 1975 Jan;57(1):10–16. [PubMed] [Google Scholar]
  50. Rabbitts T. H. The clinical significance of fusion oncogenes in cancer. N Engl J Med. 1998 Jan 15;338(3):192–194. doi: 10.1056/NEJM199801153380311. [DOI] [PubMed] [Google Scholar]
  51. Raskind W. H., Conrad E. U., Chansky H., Matsushita M. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet. 1995 May;56(5):1132–1139. [PMC free article] [PubMed] [Google Scholar]
  52. Renwick P. J., Reeves B. R., Dal Cin P., Fletcher C. D., Kempski H., Sciot R., Kazmierczak B., Jani K., Sonobe H., Knight J. C. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. Cytogenet Cell Genet. 1995;70(1-2):58–63. doi: 10.1159/000133992. [DOI] [PubMed] [Google Scholar]
  53. Rydholm A., Berg N. O., Gullberg B., Thorngren K. G., Persson B. M. Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the inter-relationships between clinical and morphologic variables. Acta Pathol Microbiol Immunol Scand A. 1984 Sep;92(5):363–374. [PubMed] [Google Scholar]
  54. Rydholm A., Mandahl N., Heim S., Kreicbergs A., Willén H., Mitelman F. Malignant fibrous histiocytomas with a 19p+ marker chromosome have increased relapse rate. Genes Chromosomes Cancer. 1990 Nov;2(4):296–299. doi: 10.1002/gcc.2870020407. [DOI] [PubMed] [Google Scholar]
  55. Sainati L., Scapinello A., Montaldi A., Bolcato S., Ninfo V., Carli M., Basso G. A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12). Cancer Genet Cytogenet. 1993 Dec;71(2):144–147. doi: 10.1016/0165-4608(93)90020-m. [DOI] [PubMed] [Google Scholar]
  56. Sankary S., Dickman P. S., Wiener E., Robichaux W., Swaney W. P., Malone P. S., Gollin S. M. Consistent numerical chromosome aberrations in congenital fibrosarcoma. Cancer Genet Cytogenet. 1993 Feb;65(2):152–156. doi: 10.1016/0165-4608(93)90225-b. [DOI] [PubMed] [Google Scholar]
  57. Schleiermacher G., Peter M., Michon J., Zucker J. M., Thomas G., Magdelénat H., Delattre O. A multiplex PCR assay for routine evaluation of deletion of the short arm of chromosome 1 in neuroblastoma. Eur J Cancer. 1995;31A(4):535–538. doi: 10.1016/0959-8049(95)00008-7. [DOI] [PubMed] [Google Scholar]
  58. Schmidt D., Thum P., Harms D., Treuner J. Synovial sarcoma in children and adolescents. A report from the Kiel Pediatric Tumor Registry. Cancer. 1991 Mar 15;67(6):1667–1672. doi: 10.1002/1097-0142(19910315)67:6<1667::aid-cncr2820670631>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  59. Schoenmakers E. F., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., Van de Ven W. J. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet. 1995 Aug;10(4):436–444. doi: 10.1038/ng0895-436. [DOI] [PubMed] [Google Scholar]
  60. Sciot R., Akerman M., Dal Cin P., De Wever I., Fletcher C. D., Mandahl N., Mertens F., Mitelman F., Rosai J., Rydholm A. Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas: a report of the CHAMP Study Group. Am J Surg Pathol. 1997 Apr;21(4):441–444. doi: 10.1097/00000478-199704000-00010. [DOI] [PubMed] [Google Scholar]
  61. Scrable H., Witte D., Shimada H., Seemayer T., Sheng W. W., Soukup S., Koufos A., Houghton P., Lampkin B., Cavenee W. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer. 1989 Sep;1(1):23–35. doi: 10.1002/gcc.2870010106. [DOI] [PubMed] [Google Scholar]
  62. Shimada H., Newton W. A., Jr, Soule E. H., Beltangady M. S., Maurer H. M. Pathology of fatal rhabdomyosarcoma. Report from Intergroup Rhabdomyosarcoma Study (IRS-I and IRS-II). Cancer. 1987 Feb 1;59(3):459–465. doi: 10.1002/1097-0142(19870201)59:3<459::aid-cncr2820590318>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  63. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  64. Skuse G. R., Kosciolek B. A., Rowley P. T. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer. 1989 Sep;1(1):36–41. doi: 10.1002/gcc.2870010107. [DOI] [PubMed] [Google Scholar]
  65. Sorensen P. H., Lessnick S. L., Lopez-Terrada D., Liu X. F., Triche T. J., Denny C. T. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994 Feb;6(2):146–151. doi: 10.1038/ng0294-146. [DOI] [PubMed] [Google Scholar]
  66. Sorensen P. H., Shimada H., Liu X. F., Lim J. F., Thomas G., Triche T. J. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res. 1995 Mar 15;55(6):1385–1392. [PubMed] [Google Scholar]
  67. Sreekantaiah C., Karakousis C. P., Leong S. P., Sandberg A. A. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer. 1992 May 15;69(10):2484–2495. doi: 10.1002/1097-0142(19920515)69:10<2484::aid-cncr2820691017>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  68. Sreekantaiah C., Ladanyi M., Rodriguez E., Chaganti R. S. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol. 1994 Jun;144(6):1121–1134. [PMC free article] [PubMed] [Google Scholar]
  69. Sørensen S. A., Mulvihill J. J., Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986 Apr 17;314(16):1010–1015. doi: 10.1056/NEJM198604173141603. [DOI] [PubMed] [Google Scholar]
  70. Taubert H., Berger D., Hinze R., Meye A., Würl P., Hogendoorn P. C., Holzhausen H. J., Schmidt H., Rath F. W. How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone? Cancer Lett. 1998 Jan 30;123(2):147–151. doi: 10.1016/s0304-3835(97)00423-0. [DOI] [PubMed] [Google Scholar]
  71. Turc-Carel C., Dal Cin P., Limon J., Rao U., Li F. P., Corson J. M., Zimmerman R., Parry D. M., Cowan J. M., Sandberg A. A. Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1981–1985. doi: 10.1073/pnas.84.7.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Turc-Carel C., Limon J., Dal Cin P., Rao U., Karakousis C., Sandberg A. A. Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet. 1986 Dec;23(4):291–299. doi: 10.1016/0165-4608(86)90011-7. [DOI] [PubMed] [Google Scholar]
  73. Zoubek A., Dockhorn-Dworniczak B., Delattre O., Christiansen H., Niggli F., Gatterer-Menz I., Smith T. L., Jürgens H., Gadner H., Kovar H. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol. 1996 Apr;14(4):1245–1251. doi: 10.1200/JCO.1996.14.4.1245. [DOI] [PubMed] [Google Scholar]
  74. Zucman J., Delattre O., Desmaze C., Epstein A. L., Stenman G., Speleman F., Fletchers C. D., Aurias A., Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet. 1993 Aug;4(4):341–345. doi: 10.1038/ng0893-341. [DOI] [PubMed] [Google Scholar]
  75. de Alava E., Kawai A., Healey J. H., Fligman I., Meyers P. A., Huvos A. G., Gerald W. L., Jhanwar S. C., Argani P., Antonescu C. R. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol. 1998 Apr;16(4):1248–1255. doi: 10.1200/JCO.1998.16.4.1248. [DOI] [PubMed] [Google Scholar]
  76. de Alava E., Ladanyi M., Rosai J., Gerald W. L. Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay. Am J Pathol. 1995 Dec;147(6):1584–1591. [PMC free article] [PubMed] [Google Scholar]
  77. de Leeuw B., Suijkerbuijk R. F., Olde Weghuis D., Meloni A. M., Stenman G., Kindblom L. G., Balemans M., van den Berg E., Molenaar W. M., Sandberg A. A. Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genet Cytogenet. 1994 Apr;73(2):89–94. doi: 10.1016/0165-4608(94)90191-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES